Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine
Public ClinicalTrials.gov record NCT02837575. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of Herpes Simplex Virus, Type 2 (HSV-2) Therapeutic DNA Vaccine in Adults With Symptomatic Genital HSV-2 Infection
Study identification
- NCT ID
- NCT02837575
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vical
- Industry
- Enrollment
- 261 participants
Conditions and interventions
Conditions
Interventions
- VCL-HB01 Biological
- Phosphate-buffered saline Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2016
- Primary completion
- Mar 31, 2018
- Completion
- Nov 30, 2018
- Last update posted
- Feb 26, 2019
2016 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Vaccine Research Clinic at University of Alabama at Birmingham | Birmingham | Alabama | 35294-2050 | — |
| Medical Center for Clinical Research | San Diego | California | 92108 | — |
| QPS Broward Research | Hollywood | Florida | 33024 | — |
| QPS Miami Research Associates | South Miami | Florida | 33143 | — |
| Comprehensive Clinical Trials, LLC | West Palm Beach | Florida | 33409 | — |
| University of Illinois | Chicago | Illinois | 60612 | — |
| Indiana University Infectious Disease Research | Indianapolis | Indiana | 46202 | — |
| Heartland Research Associates, LLC | Wichita | Kansas | 67207 | — |
| Central Kentucky Research Associates, Inc. | Lexington | Kentucky | 40509 | — |
| The Center for Pharmaceutical Research | Kansas City | Missouri | 64114 | — |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | — |
| University of North Carolina (UNC) Institute of Global Health and Infectious Diseases | Chapel Hill | North Carolina | 27599 | — |
| Clinical Research Associates, Inc. | Nashville | Tennessee | 37203 | — |
| University of Utah School of Medicine - Division of Infectious Diseases | Salt Lake City | Utah | 84132 | — |
| University of Washington | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02837575, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2019 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02837575 live on ClinicalTrials.gov.